Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.7K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.7K
Cancer Survival Analysis01:21

Cancer Survival Analysis

548
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
548
Mouse Models of Cancer Study02:43

Mouse Models of Cancer Study

6.2K
Mice have long served as models for studying human biology and pathology because of their phylogenetic and physiological similarity with humans. They are also easy to maintain and breed in the laboratory, and hence, many inbred strains are now available for research. Studies on mice have contributed immeasurably to our understanding of cancer biology.
The development of transgenic, knockout, and knock-in mice has led to an exponential increase in their use as model organisms in research,...
6.2K
Treatment Resistant Cancers02:56

Treatment Resistant Cancers

3.5K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.5K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Metachronous contralateral recurrence in upper tract urothelial carcinoma: a multi-institutional competing-risks analysis from the ROBUUST 3.0 registry.

Urology practice·2026
Same author

Phase 2 Trial of Intravesical Gemcitabine and Docetaxel as First-Line Treatment of Bacillus Calmette-Guérin (BCG)‒Naïve Non-Muscle-Invasive Urothelial Carcinoma: Updated, 3-Year Outcomes.

The Journal of urology·2026
Same author

1H MR-based detection of human plasma metabolic alterations in clear cell renal cell carcinoma.

BJUI compass·2026
Same author

Renal function outcomes following endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026
Same author

Patterns of adjuvant intracavitary instillation and recurrence after endoscopic management of upper tract urothelial carcinoma.

World journal of urology·2026
Same author

Presentation, management, and outcomes of testicular germ cell tumors by age.

Urologic oncology·2026

Related Experiment Video

Updated: Dec 1, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K

Harnessing Big Data with Machine Learning in Precision Oncology.

Nirmish Singla1, Shyamli Singla2

  • 1Urology Service, Department of Surgery, Memorial Sloan Kettering Cancer Center, New York, NY.

Kidney Cancer Journal : Official Journal of the Kidney Cancer Association
|November 9, 2020
PubMed
Summary
This summary is machine-generated.

Machine learning can interpret tumor appearance to provide patient-level data for precision oncology. This artificial intelligence approach aims to make complex molecular data clinically actionable for better cancer care.

More Related Videos

Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.7K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

Related Experiment Videos

Last Updated: Dec 1, 2025

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma
04:09

Predicting Treatment Response to Image-Guided Therapies Using Machine Learning: An Example for Trans-Arterial Treatment of Hepatocellular Carcinoma

Published on: October 10, 2018

8.5K
Constructing and Visualizing Models using Mime-based Machine-learning Framework
06:19

Constructing and Visualizing Models using Mime-based Machine-learning Framework

Published on: July 22, 2025

1.7K
Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model
07:15

Machine Learning Algorithms for Early Detection of Bone Metastases in an Experimental Rat Model

Published on: August 16, 2020

7.2K

Area of Science:

  • Oncology
  • Bioinformatics
  • Artificial Intelligence

Background:

  • Multi-level molecular "omic" analyses offer deep insights into cancer biology.
  • Translating complex omics data into clinically relevant information for patient care remains a significant challenge.
  • Current limitations in cost and interpretability hinder routine clinical application of molecular studies.

Purpose of the Study:

  • To propose machine learning as a key solution for accurate and efficient precision oncology.
  • To explore the potential of artificial intelligence in interpreting tumor phenotype for clinical data generation.
  • To bridge the gap between molecular data and clinical decision-making in cancer treatment.

Main Methods:

  • Training deep learning models to analyze histopathologic and radiographic tumor features.
  • Utilizing tumor and microenvironment appearance as a proxy for underlying molecular biology.
  • Developing an artificial intelligence framework for data interpretation.

Main Results:

  • Interpreting phenotypic data can yield relevant patient-level diagnostic, prognostic, and therapeutic information.
  • Deep learning models show potential in extracting actionable insights from tumor appearance.
  • The proposed AI framework facilitates the interpretation of complex biological data.

Conclusions:

  • Machine learning offers a viable path towards efficient and accurate precision oncology.
  • AI-driven interpretation of tumor phenotype can provide essential patient-level data.
  • This approach has the potential to foster multidisciplinary collaboration and advance cancer care.